LCM
KYTH

Laurion Capital Management’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Laurion Capital Management’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-16,650
Closed -$620K – 346
2013
Q4 		$620K Buy
+16,650
New +$691K 0.02% 142

Other funds holding KYTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Laurion Capital Management's KYTH Position: Q1 2014 in Review

Laurion Capital Management sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q1 2014, closing a stake of 16,650 shares — an estimated $620K sold.

Laurion Capital Management first reported a position in KYTH in Q4 2013 and held it in 1 quarter. The position peaked at $620K in Q4 2013. 102 funds tracked by Wall St. Rank hold KYTH as of Q1 2014.

  • Laurion Capital Management reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q1 2014 after selling out during the quarter.
  • Laurion Capital Management sold 16,650 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q1 2014, an estimated $620K.
  • Laurion Capital Management first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q4 2013 and held it in 1 quarter.
  • Laurion Capital Management's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $620K in Q4 2013.
  • 102 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q1 2014.

Based on Laurion Capital Management's 13F filing for Q1 2014, filed 13 May 2014.